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242Objective:We developed a new thoracoscopic ablation procedure for lone atrial fibrillation (AF) based on new
endoscopic technology and the adoption of new types of energy.
Methods: Fifty-five patients with lone atrial fibrillation underwent this therapy. Patient age ranged from 30 to 81
years and there were 39 men and 16 women. Of these patients, 38 had paroxysmal atrial fibrillation, 14 had per-
sistent atrial fibrillation, and 3 had longstanding atrial fibrillation. The procedure was performed on the beating
heart through 3 ports in the left chest wall. Pulmonary vein isolation and ablation of the left atriumwere achieved
by bipolar radiofrequency ablation. Ganglionic plexus ablation was completed using the ablation pen. The left
atrial appendage was excluded.
Results: Mean procedure duration was 106.6  42.8 minutes. No conversion to sternotomy or pacemaker
implantation occurred and no patients died. Their hospital stay was 5.3  2.0 days with a mean follow-up of
12.6  2.2 months. Forty-nine of 55 patients (89.1%) patients were in sinus rhythm. Six patients could not
maintain sinus rhythm. Thrombus in the left atrium and stenosis of the pulmonary vein were not found postop-
eratively.
Conclusions: This less invasive procedure proved to be safe and presented optimistic outcomes, so it deserves to
be promoted as a treatment for lone atrial fibrillation. (J Thorac Cardiovasc Surg 2014;147:242-6)Atrial fibrillation (AF) affects more and more patients in
modern society,1 and leads to increased incidence of stroke,
heart failure, and mortality.2,3 Improving recovery from AF
is a hot topic. Maintaining sinus rhythm by antiarrhythmic
drugs is difficult.4 The efficacy of catheter ablation is also
unsatisfactory and associated with serious complications.5
The Cox Maze III procedure has the top success rate of
95% but it has not been widely adopted for the complexity
of incisions and suturing.6 The problem is solved in part by
the emergence of new types of energy, such as radiofrequen-
cies, microwaves, freezing, and so forth.7 The Maze III pro-
cedure modified by the replacement of energy is adopted for
its satisfactory recovery rate, but considerable concomitant
trauma needs to be lessened, especially for patients with
lone AF.
Wolf and colleagues8 introduced a surgical treatment for
lone AF through an epicardial approach on the beating heart
by thoracoscopic technique. The main components of this
procedure are bilateral pulmonary vein isolation (PVI) us-
ing a bipolar radiofrequency ablation device, resection ofe Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medi-
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The Journal of Thoracic and Cardiovascular Surgthe left atrial appendage, ablation of the ganglionic plexus
(GP), and division of the ligament of Marshall. After treat-
ment, about 90% patients are free of AF and accompanying
trauma is reduced compared with previous procedures.8 The
procedure of Wolf and colleagues8 requires 2 1-cm ports
and 1 5-cm incision in both sides of the chest wall for the
camera and ablation device. Yilmaz and associates9 devel-
oped a procedure for thoracoscopic ablation in 2007. The
5-cm incision is replaced by 2 ports. The procedure be-
comes completely thoracoscopic; however, it still requires
the ports on both sides of the chest wall, and ablation of
the left atrium cannot be achieved. We introduce a less in-
vasive procedure that allows for ablation of bilateral pulmo-
nary veins, resection of the left atrial appendage, GP
ablation, and ablation of the left atrium using a bipolar ra-
diofrequency clamp that requires only 3 ports in the left
chest wall.METHODS
Patient Selection
Between October 2010 and June 2012, 55 patients with lone AF under-
went the procedure. The study protocol was approved by the institutional
review board, and informed consent was received from all patients. Patients
with symptomatic AF between 30 years and 81 years of age were selected
on the basis of the Heart Rhythm Society/European Heart Rhythm Associ-
ation/European Cardiac Arrhythmia Society Expert Consensus Statement
and the following inclusion criteria10: drug-refractory AF, failed catheter
ablation, history of stroke or embolism, or left ventricular ejection fraction
of 30% or more. Previous cardiac or lung surgery, and a left atrium>70
mm were relative contraindications. Patient characteristics are detailed in
Table 1. Preoperative AF-related histories are listed in Table 2.ery c January 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
GP ¼ ganglionic plexus
PVI ¼ pulmonary vein isolation
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DSurgical Technique
All 55 procedures were performed by Dr Mei after general anesthesia
was administered to the patient with a double-lumen endotracheal tube.
Transesophageal echocardiogram was performed in the operating room
to verify the absence of left atrial thrombus. During the procedure, the
patient was positioned in the right lateral decubitus position. The proce-
dure was performed through 3 ports around the subscapular angle line of
the left chest wall. The camera port (10 mm) was introduced in the eighth
intercostal space at the subscapular angle line. The first working port (25
mm) was introduced about 30 mm anterior to the subscapular angle line
in the sixth intercostal space. The second working port (10 mm) was in-
troduced 30 mm posterior to the subscapular angle line in the seventh in-
tercostal space (Figure 1, A). The pericardium was opened a few
centimeters anterior to the descending aorta after the dissection of liga-
ment of inferior lung. The bilateral pulmonary veins and the posterior
left atrium were exposed after the suspension of the pericardium. Blunt
dissection around the pulmonary veins was performed using the AtriCure
Lumitip Dissector (AtriCure, Inc, West Chester, Ohio) and PVI was
achieved by bipolar radiofrequency ablation with the AtriCure Isolator
Synergy ablation clamp (AtriCure, Inc). At least 10 times overlapping ab-
lation lesions were performed at the antrum of the right and left pulmo-
nary vein (Figure 1, B and C). Electrical isolation of all pulmonary veins
was tested using the AtriCure Synergy ablation pen (AtriCure, Inc). The
linear lesion from the left inferior pulmonary vein to the right superior
pulmonary vein could also be made by clamp after isolating the top of
the left atrium (Figure 1, D). Other linear lesions on the left atrium
were made using the AtriCure Synergy ablation pen. Linear lesions of
the left atrium included left pulmonary vein to incision of left atrial ap-
pendage, left inferior pulmonary vein to the mitral valve annulus. The ab-
lation of 3 circles and 2 lines on the left atrium were undertaken easily by
direct vision (Figure 1, E). The ablation of the GP on the epicardium was
also made using the AtriCure Isolator Synergy ablation pen. The left
atrial appendage was excluded using an EZ 45 stapler (Ethicon Endo-
Surgery, Inc, Cincinnati, Ohio) (Figure 1, F). After these steps, cardiover-
sion was performed immediately if AF did not stop.
Postoperative Medical Management
Amiodarone was administered to patients at 200 mg/day for 3 months
after the procedures and was then tapered in the presence of a stable sinus
rhythm. Postoperative anticoagulation by warfarin or aspirin followed the
score of CHA2DS2-VAS2 (Congestive Heart Failure, Hypertension, Age
75 years [double], Diabetes mellitus, Stroke [double], Vascular disease,
age 65-74, sex category [female]) and HAS-BLED (Hypertension, Abnor-
mal renal and liver Function, Stroke, Bleeding, Labile INRs, Elderly, Drugs
or alcohol). Anticoagulant drugs were discontinued if sinus rhythm was
present 3 months after the procedure. Electrical cardioversion was per-
formed if a patient had symptomatic AF<48 hours or was anticoagulated
adequately.
Follow-up
Baseline characteristics, and in-hospital and follow-up data were col-
lected from clinical and outpatient clinic files. Questionnaires or telephone
calls were used for follow-up. Heart rhythm documentation was based on
electrocardiograms and 24-hour Holter (Royal Dutch Philips Electronics
Ltd, Amsterdam, The Netherlands) monitoring analysis. TransthoracicThe Journal of Thoracic and Caecho and 24-hour Holter monitoring were evaluated at discharge and 1,
3, 6, and 12 months postoperatively. The procedure was considered to be
unsuccessful if an episode of AF (of a duration>30 seconds independent
of amount of episodes or symptoms) occurred after a blanking period of
3 months.
Statistical Analysis
Data are presented as mean  standard deviation.RESULTS
The procedure was completed successfully for all
patients. The acute procedural success rate was 100%.
There was no conversion to sternotomy or thoracotomy.
The average procedure time was 106.6  42.8 minutes
(range, 81-239 minutes). Eleven patients (20.0%) received
cardioversion after ablation in the operation room. One pa-
tient had failed electrical cardioversion. Mean bleeding was
about 50 mL and no patient received blood products intra-
operatively or during hospitalization. There were nomortal-
ities in this population. No patient required pacemaker
insertion. Two patients had onset of sinus tachycardia after
the procedure. The sinus tachycardia stopped on its own and
sinus rhythm was maintained until the data were collected.
No obvious complications occurred after the procedures.
Two patients (4%) had early AF recurrence after cardiover-
sion. Cardioversion was performed on them before dis-
charge. One of them had failed electrical cardioversion;
the other was successful. There was another patient who
still had paroxysmal AF. Patients were discharged after
a mean hospitalization of 5.3  2.0 days (range, 4-14
days). Fifty-two patients (94.5%) maintained a sinus
rhythm when they were discharged. In-hospital results are
summarized in Table 3. One patient was readmitted 4 weeks
after discharge for pleural effusion and was treated by thor-
acostomy drain and oral steroid administration.
The mean follow-up duration was 12.6  2.2 months.
Forty-nine of 55 patients were free of AF, as confirmed
by electrocardiograms or 24-hour Holter monitoring. All
were asymptomatic. The 1-year success rate was 89.1%.
One patient, discharged with AF, who could not maintain
a sinus rhythm before the procedure by oral amiodarone ad-
ministration, recovered a sinus rhythm after the use of amio-
darone 1 month later. Six patients (3 with paroxysmal AF
and 3 with persistent/longstanding AF) could not maintain
a sinus rhythm after the procedure. Four of these 6 patients
had early recurrence (1 patient with paroxysmal AF and 3
patients with persistent/longstanding AF). Freedom from
AF was 92.1% (35/38) and 82.4% (14/17) for paroxysmal
AF and persistent/longstanding AF, respectively. Forty-nine
patients evaluated beyond 3 months had been weaned suc-
cessfully from antiarrhythmic drugs. Three months after
the procedure, all computed tomographic and echocardio-
graphic results were normal (no pulmonary vein stenosis
or thrombus in the left atrium).rdiovascular Surgery c Volume 147, Number 1 243
TABLE 1. Patient characteristics
Characteristics Results
Sex, male,% (no. of males/no. of females) 70.9 (39/16)
Age, y; mean  SD 59.2  15.4
Paroxysmal AF, n 38
Persistent AF, n 14
Longstanding persistent AF, n 3
NYHA class I, n 37
NYHA class II, n 14
NYHA class III, n 4
LA diameter, mm; mean  SD 43.2  6.3
Duration of AF, y; mean  SD 7.6  7.2
SD, Standard deviation; AF, atrial fibrillation; NYHA, New York Heart Association;
LA, left atrium.
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DDISCUSSION
Atrial fibrillation is themost common cardiac arrhythmia,
but optimal therapy for AF has still not been discovered. The
best aim of AF treatment is to achieve and maintain a sinus
rhythm that results in fewer symptoms, decreased stroke risk
and mortality, freedom from the antiarrhythmic drugs and
anticoagulation, and an improved quality of life.11 The
95% sinus rhythm recovery rate reported by Cox is the top
success rate, but few surgeons adopt the Cox Maze III pro-
cedure, which requires cardiopulmonary bypass and an
arrested heart.12 The crossclamp time for a lone Cox Maze
III procedure is about 60 to 120 minutes.12 Pacemakers are
used in 15% of patients and the median length of stay is 9
to 12 days. Moreover, the procedure has significant morbid-
ity. Catheter-based ablation is prevalent for its decreased
pain and increased safety comparedwith theMaze III proce-
dure. The deficiencies of this method include a limited suc-
cess rate, a high incidence of recurrence, and associated
serious complications such as stenosis of pulmonary veins,
transesophageal fistulas, and so forth.13 It is inevitable that
there are gaps createdwhen performing a line of endocardial
ablation dots, and the amount of energy applied during the
procedure must be limited to avoid atrial perforation and
transesophageal fistulas. The integrity and transmurality ofTABLE 2. Preoperative atrial fibrillation-related histories
Characteristics Results, n
Hypertension 38
Diabetes mellitus 14
Stroke/arterial embolism 5
Alcoholic history 7
Smoking history 23
Catheter ablation 7
Permanent pacemaker implantation 2
Digoxin 16
Betaloc 38
Amiodarone 40
Aspirin 42
Warfarin 30
244 The Journal of Thoracic and Cardiovascular Surgablation cannot be guaranteed.14 Therefore, an ideal proce-
dure should include a beating heart approach, intact trans-
mural ablation, and minimal invasion.
The problemsmentioned earlier were solved in part using
the Wolf mini Maze procedure. Pulmonary vein isolation,
GP ablation, and left atrial appendage amputation—the
main components of the Wolf procedure—can also be
done with our procedure. The intact, transmural isolation
of pulmonary vein can be made by bipolar radiofrequency
clamp on the beating heart.15 The excision of the left atrial
appendage avoids production of thrombus to decrease effec-
tively the incidence of stroke and embolism.16 The GP has
an important influence on the generation and aggravation of
AF.17 Scherlag and colleagues18 found that additional GP
ablation had a better outcome in a prospective study that
compared PVI with and without GP ablation. It was an
encouraging result; however, the success rate should be fur-
ther improved. About 90% of patients with paroxysmal AF
are in normal sinus rhythm; patients with persistent and
permanent AF are just 20% to 70%.14,19 Additional
ablation should be undertaken for a greater recovery rate,
especially for persistent and permanent AF.
Most spontaneous initiation of paroxysmal AF originates
in the pulmonary veins.20 That is why the efficacy of PVI is
higher in paroxysmal AF.21 However, the posterior left
atrium is also an important source that initiates and drives
AF.22 It should be more effective if we could remove the
foci on the posterior left atrium with direct vision. In addi-
tion to those triggers stated earlier, change of substrate of
atrial tissue is related strongly to persistent and permanent
AF.23 Therefore, only PVI, even with transmurality of abla-
tion ensured and GPs ablation assisted, was not enough for
persistent AF. It was inevitable that the success rate of treat-
ing persistent AF was poor. For these patients, we first need
to make a more extensive linear lesion set, mimicking the
Cox Maze III left atrial lesions, to prevent macro reen-
try.24,25 Second, we need to ensure the transmurality and
continuity of the linear lesion. The linear lesion made
using the bipolar radiofrequency clamp is currently the
best way to ensure transmurality and continuity.15 Our
approach allows accurate, transmural, and continuous linear
lesion on the left atrium by using a bipolar radiofrequency
clamp. It was the first time to expose the posterior left
atrium from epicardium from left chest wall. The ablation
of 3 circles and 2 lines on the left atrium were achieved eas-
ily with direct vision. Meanwhile, any foci on the posterior
left atrium could also be ablated. Our data show a recovery
rate this is no less than that of Wolf and colleagues.8
Whether a better recovery rate can be achievedmust be con-
firmed by more cases and further follow-up.
A minimally invasive procedure is one direction for fu-
ture surgery. Ablation from epicardium enables this proce-
dure to be performed on a beating heart without
cardiopulmonary bypass. The sternotomy or rib-spreadingery c January 2014
FIGURE 1. Complete thoracoscopic ablation of the left atrium. (A) The entire procedure is performed thoracoscopically through 3 ports on the left chest
wall. The black lines with numbers indicate the intercostal spaces. The red lines show the position of the ports. (B) The bipolar radiofrequency ablation
clamp is placed around the left pulmonary vein. (C) The bipolar radiofrequency ablation clamp is placed around the right pulmonary vein. (D) The linear
lesion from the left inferior pulmonary vein to the right superior pulmonary vein by the bipolar radiofrequency ablation clamp. (E) The ablation of 3 circles
and 2 lines on the left atrium. (F) Amputation of the left atrial appendage with a stapler. PV, Pulmonary vein; SVC, superior vena cava; IVC, inferior
vena cava.
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the first to ablate the bilateral pulmonary veins via the left
chest wall. In addition, it is easier to perform than previous
surgical procedures. Therefore, we have reason to believe
our procedure will be widely adopted for its efficacy, safety,
convenience, and minimal invasion.TABLE 3. Patient outcomes
Outcome Results
Mortality, n 0
Procedure time, min 106.6  42.8
Conversion to sternotomy, n 0
Cardioversion in OR, n 11
Cardioversion before discharge, n 2
Discharged with AF, n 3
Hospital stay, d 5.3  2.0
Recurrence, n 6
Sinus rhythm without AADs, n 49
OR, Operating room; AF, atrial fibrillation; AADs, antiarrhythmic drugs.
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